Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines
Top Cited Papers
Open Access
- 22 December 2013
- journal article
- review article
- Published by Hindawi Limited in ISRN Inflammation
- Vol. 2013, 1-12
- https://doi.org/10.1155/2013/139239
Abstract
Adipose tissue is a complex organ that comprises a wide range of cell types with diverse energy storage, metabolic regulation, and neuroendocrine and immune functions. Because it contains various immune cells, either adaptive (B and T lymphocytes; such as regulatory T cells) or innate (mostly macrophages and, more recently identified, myeloid-derived suppressor cells), the adipose tissue is now considered as a bona fide immune organ, at the cross-road between metabolism and immunity. Adipose tissue disorders, such as those encountered in obesity and lipodystrophy, cause alterations to adipose tissue distribution and function with broad effects on cytokine, chemokine, and hormone expression, on lipid storage, and on the composition of adipose-resident immune cell populations. The resulting changes appear to induce profound consequences for basal systemic inflammation and insulin sensitivity. The purpose of this review is to synthesize the current literature on adipose cell composition remodeling in obesity, which shows how adipose-resident immune cells regulate inflammation and insulin resistance—notably through cytokine and chemokine secretion—and highlights major research questions in the field.Keywords
Funding Information
- Centre National de la Recherche Scientifique
This publication has 120 references indexed in Scilit:
- Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastaseNature Medicine, 2012
- IL-7: The global builder of the innate lymphoid network and beyond, one niche at a timeSeminars in Immunology, 2012
- Human resistin: found in translation from mouse to manTrends in Endocrinology & Metabolism, 2011
- Leptin Activates Human B Cells to Secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 Signaling PathwayJournal of Clinical Immunology, 2011
- Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patientsEuropean Journal of Applied Physiology, 2010
- Interleukin‐6 maintains bone marrow‐derived mesenchymal stem cell stemness by an ERK1/2‐dependent mechanismJournal of Cellular Biochemistry, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Nutrient sensing and inflammation in metabolic diseasesNature Reviews Immunology, 2008
- Inflammation and metabolic disordersNature, 2006